Table 1.

Drugs potentially interacting with statins to increase myopathy risk.

CYP3A4 Inhibitors	CYP2C9 Inhibitors	OATP1B1 Inhibitors	Glucuronidation Inhibitors
Protease inhibitors Macrolide antibiotics Azole antifungals Non-dihydropyridine calcium channel blockers (diltiazem and verapamil) Antidepressants (nefazodone) Cyclosporine Amiodarone Drinking large amounts of grapefruit juice or cranberry juice (N250 mL per day)	Fluconazole Amiodarone Fenofibrate (mild-to-moderate effect)	Cyclosporine Protease inhibitors	Gemfibrozil